Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Commitments And Contingencies Disclosure [Line Items] | |||
| Operating lease, discount rate (as a percent) | 13.00% | ||
| Operating lease, remaining term | 1 year 6 months | ||
| Rent expense | $ 0.2 | $ 0.1 | |
| Cash payments related to operating lease | $ 0.2 | $ 0.2 | |
| GenFleet Therapeutics (Shanghai) Inc | |||
| Commitments And Contingencies Disclosure [Line Items] | |||
| Upfront fee | $ 10.0 | ||
| Eligible payment from collaboration for development and regulatory milestone achievement under collaborations agreement | 48.0 | ||
| Maximum amount eligible for milestones under collaborations agreement | $ 92.0 | ||